Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Basilea
>
US Division
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 2006985"]THANKS.</p><p><br /></p><p>Basilea Pharmaceuticals, Inc. Appoints National Sales Director </p><p><br /></p><p> NewswireToday - /newswire/ - Hingham, MA, United States, 10/09/2007 - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug.</p><p> </p><p> </p><p> Phillips DiPisa, a retained executive search firm serving healthcare providers, managed care organizations, and life sciences firms, today announced that it has completed an executive search assignment for Basilea Pharmaceuticals, Inc.</p><p><br /></p><p>Basilea Pharmaceuticals, Inc., a newly launched U.S. subsidiary of Switzerland's Basilea Pharmaceutica, hired Ken Farah as the National Sales Director. Phillips DiPisa led the search on behalf of Basilea Pharmaceuticals.</p><p><br /></p><p>At Basilea, Farah will lead the company’s first sales team for Ceftobiprole, which is awaiting FDA approval to treat methicillin-resistant staff infections.</p><p><br /></p><p>Farah has over 25 years of sales and sales management experience launching specialty anti-infective and oncology products in the hospital markets. Most recently, Farah was a Sales Director for Dendreon Corporation. Prior, he managed regions around the country for Ortho McNeil/Alza, where he helped build the specialty sales force for the ADHD drug Concerta.</p><p><br /></p><p>Farah also served at ALZA, Sequus and Immunex, in capacities such as Regional Manager, Director of Strategic Oncology accounts and Oncology Account Executive. He began his career in sales at Lederle, where he rose to management in the hospital division and concentrated on antibiotic sales in the hospital marketplace.</p><p><br /></p><p>Basilea Pharmaceutica Ltd. is a biopharmaceutical company focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea’s products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio, including three investigational phase III drugs of which two have shown positive pivotal phase III results.</p><p><br /></p><p>Kevin Carroll was Phillips DiPisa’s associate responsible for this engagement.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 2006985"]THANKS. Basilea Pharmaceuticals, Inc. Appoints National Sales Director NewswireToday - /newswire/ - Hingham, MA, United States, 10/09/2007 - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug. Phillips DiPisa, a retained executive search firm serving healthcare providers, managed care organizations, and life sciences firms, today announced that it has completed an executive search assignment for Basilea Pharmaceuticals, Inc. Basilea Pharmaceuticals, Inc., a newly launched U.S. subsidiary of Switzerland's Basilea Pharmaceutica, hired Ken Farah as the National Sales Director. Phillips DiPisa led the search on behalf of Basilea Pharmaceuticals. At Basilea, Farah will lead the company’s first sales team for Ceftobiprole, which is awaiting FDA approval to treat methicillin-resistant staff infections. Farah has over 25 years of sales and sales management experience launching specialty anti-infective and oncology products in the hospital markets. Most recently, Farah was a Sales Director for Dendreon Corporation. Prior, he managed regions around the country for Ortho McNeil/Alza, where he helped build the specialty sales force for the ADHD drug Concerta. Farah also served at ALZA, Sequus and Immunex, in capacities such as Regional Manager, Director of Strategic Oncology accounts and Oncology Account Executive. He began his career in sales at Lederle, where he rose to management in the hospital division and concentrated on antibiotic sales in the hospital marketplace. Basilea Pharmaceutica Ltd. is a biopharmaceutical company focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea’s products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio, including three investigational phase III drugs of which two have shown positive pivotal phase III results. Kevin Carroll was Phillips DiPisa’s associate responsible for this engagement.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Basilea
>
US Division
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Basilea
>
US Division
>